← back to search

Xiaoqiong Li

Beijing Institute of Technology · CN
Area of research
Biomedical Engineering · Molecular Biology
Research interest
Research focused on Gut flora and Fermentation, with related work in Type 2 diabetes, Myricetin, Grape seed extract. Notable publications include 'Myricetin relieves the symptoms of type 2 diabetes mice and regulates intestinal microflora', 'The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice', and 'Exploring the mechanism of probiotics in enhancing the utilization of chemical components (or polyphenols) of grape seed extract'.
h-index
citations
18
works
3
NIH funding
primary concept
email

Recent publications

Astragalus polysaccharide modulates the gut microbiota and metabolites of patients with major depressive disorder in an in vitro fermentation model: a pilot study
Frontiers in Nutrition 2025cited by 8position: middledoi
Enhancing Akkermansia growth via phytohormones: a strategy to modulate the gut-bone axis in postmenopausal osteoporosis therapy
Journal of Translational Medicine 2025cited by 7position: middledoi
In vitro digestion and fermentation of jujube-derived polysaccharide PZMP3 and its modulatory effect on gut microbiota and metabolic pathways
Food Chemistry X 2025cited by 2position: firstdoi
A Graphene Composite Film Based Wearable Far‐Infrared Therapy Apparatus (GRAFT) for Effective Prevention of Postoperative Peritoneal Adhesion
Advanced Science 2024cited by 10position: middledoi
Exploring the mechanism of probiotics in enhancing the utilization of chemical components (or polyphenols) of grape seed extract
Food Chemistry 2023cited by 21position: middledoi
Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
Beilstein Journal of Nanotechnology 2023cited by 17position: middledoi
Macrophage membrane-coated biomimetic magnetic nanoparticle loaded with interleukin 10 as potential candidate towards anti-atherosclerotic therapy: characterization and in vitro studies
Journal of Nanoparticle Research 2023cited by 4position: middledoi
Myricetin relieves the symptoms of type 2 diabetes mice and regulates intestinal microflora
Biomedicine & Pharmacotherapy 2022cited by 44position: middledoi
The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice
Frontiers in Nutrition 2022cited by 26position: middledoi
Prevalence of major morbidities and outcome of all hospitalized neonates. A retrospective cohort study of Huai’an neonatal survivals
Figshare 2022cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jinjun Li · Southern Medical University5 papers (2022–2025)Liying Zhu · Harbin Medical University3 papers (2022–2023)Haibiao Sun · Shanxi Medical University3 papers (2022–2025)Zhiqi Zhao · Shanxi Medical University2 papers (2022–2022)Yanfeng Meng · Shanxi Medical University2 papers (2023–2023)Donglian Du · Shanxi Medical University2 papers (2023–2023)Yueyou Peng · Shanxi Medical University2 papers (2023–2023)Xin Wang · Xian Yang Central Hospital2 papers (2022–2022)Li Li · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2022)Qilin Li · Union Hospital1 papers (2024–2024)Yanyan Wen · Shanxi Medical University1 papers (2023–2023)Jun Du · Guiyang Medical University1 papers (2025–2025)Bo Sun · Jinan Maternity And Care Hospital1 papers (2022–2022)Zhigang Zhu · Nanjing Agricultural University1 papers (2025–2025)Xiaoqiang Han · Ningxia Medical University1 papers (2025–2025)Hui Wang · Tianjin University of Traditional Chinese Medicine1 papers (2022–2022)Yunxin Ji · Ningbo University1 papers (2025–2025)Lìyǐng Zhū · Shanghai Medical College of Fudan University1 papers (2025–2025)Zhiqi Zhao · Shanxi Medical University1 papers (2025–2025)Hongni Yue · Fudan University1 papers (2022–2022)